Grant: CIHR Fellowship
Direct Payment
$150,000.00
Role of cardiac-specific knockout of GSNOR in cardioprotection following myocardial infarction (MI): Focus on gender differences
FY 2010-11
Summary
There are considerable epidemiological data showing that pre-menopausal females have reduced risk for cardiovascular disease. Compared to age-matched males, pre-menopausal women show lower incidence of left ventricular hypertrophy, coronary artery disease and cardiac remodeling following myocardial infarction. The incidence of cardiovascular disease increases in post-menopausal women. Studies in animal models have also suggested that females have reduced injury following myocardial infarction. A large body of evidence suggests that estrogen working through the nitric oxide pathway is involved in this gender-related cardiac protection, but the exact mechanism involved remains largely unknown. Nitric oxide is a highly versatile signaling molecule, and S-nitrosylation is thought to be one of the major signaling pathways through which it exerts its action. S-nitrosylation is regulated by S-nitrosogluathione reductase (GSNOR) and mice lacking the GSNOR gene show more favorable outcome following myocardial infarction, yet the mechanisms involved are not well understood. Thus, in this current study, I hypothesize the females with cardiac-specific knockout of the GSNOR gene will have more favorable outcome following myocardial infarction due to reduced myocyte apoptosis and left ventricular remodeling and improved angiogenesis. The results from these study will provide an integrated view of the role of nitric oxide and GSNOR in cardiovascular pathophysiology and also allow us to assess the role of S-nitrosylation in gender-related cardioprotective effects against ischemic injury. Our findings will also help to identify new drug targets and help to optimize treatment of heart disease in women and men. In the long term, our findings will have implications for developing new therapeutic strategies for myocardial infarction and other related cardiovascular diseases.
Department
Program
CIHR Fellowship
Recipient
Location
Florida, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
225905
Name
Kulandavelu Shathiyah
Region
Florida
Country
United States of America
Orgtype
Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Role of cardiac-specific knockout of GSNOR in cardioprotection following myocardial infarction (MI): Focus on gender differences
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Gender; Gsnor; Heart; Mouse; Myocardial Infarction; Nitric Oxide; Oxidative Stress; Physiology; S-Nitrosylation; Ultrasound
Abstract
There are considerable epidemiological data showing that pre-menopausal females have reduced risk for cardiovascular disease. Compared to age-matched males, pre-menopausal women show lower incidence of left ventricular hypertrophy, coronary artery disease and cardiac remodeling following myocardial infarction. The incidence of cardiovascular disease increases in post-menopausal women. Studies in animal models have also suggested that females have reduced injury following myocardial infarction. A large body of evidence suggests that estrogen working through the nitric oxide pathway is involved in this gender-related cardiac protection, but the exact mechanism involved remains largely unknown. Nitric oxide is a highly versatile signaling molecule, and S-nitrosylation is thought to be one of the major signaling pathways through which it exerts its action. S-nitrosylation is regulated by S-nitrosogluathione reductase (GSNOR) and mice lacking the GSNOR gene show more favorable outcome following myocardial infarction, yet the mechanisms involved are not well understood. Thus, in this current study, I hypothesize the females with cardiac-specific knockout of the GSNOR gene will have more favorable outcome following myocardial infarction due to reduced myocyte apoptosis and left ventricular remodeling and improved angiogenesis. The results from these study will provide an integrated view of the role of nitric oxide and GSNOR in cardiovascular pathophysiology and also allow us to assess the role of S-nitrosylation in gender-related cardioprotective effects against ischemic injury. Our findings will also help to identify new drug targets and help to optimize treatment of heart disease in women and men. In the long term, our findings will have implications for developing new therapeutic strategies for myocardial infarction and other related cardiovascular diseases.
Competitiondate
201102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Kulandavelu, Shathiyah
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~